BD is recalling its SmartSite Syringe Administration Sets due to leaking

0

BD is recalling its SmartSite Syringe Administration Sets due to leaking of the sets which may result in under‐infusion of critical medications, delay or interruption of infusions, contamination of the fluid paths and/or health care provider exposures to hazardous medications” FDA (2019).

Extract:

FDA report “BD is recalling its SmartSite Syringe Administration Sets due to leaking of the sets which may result in under‐infusion of critical medications, delay or interruption of infusions, contamination of the fluid paths and/or health care provider exposures to hazardous medications. Delayed infusion or under-infusion of life-sustaining medications could result in serious adverse health consequences, particularly for very low birth-weight babies (micro-preemies). Additionally, contamination of the fluid path could result in an increased risk of infection for patients. To date, BD has not received any reports of serious injury or death due to the malfunction of this device.

You may also be interested in…


Full Text

Share.

Comments are closed.